Showing results (2251-2260 of 9,904) with videos related to

Sort By:
Pageof 991
Bone Marrow Transplantation|July 1, 2014
Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: a report from the Acute Leukemia Working Party of EBMTM A Kharfan-Dabaja, M Labopin, A Bazarbachi, et al.
Bone Marrow Transplantation|July 10, 2012
Nutritional support in patients with GVHD of the digestive tract: state of the artB S van der Meij, P de Graaf, N J Wierdsma, et al.
Bone Marrow Transplantation|February 10, 2015
Outcomes after autologous SCT in lymphoma patients grouped by weightJ E Lau, C Weber, M Earl, et al.
Bone Marrow Transplantation|February 10, 2015
Clinical impact of immunophenotypic remission after allogeneic hematopoietic cell transplantation in multiple myelomaL Giaccone, L Brunello, M Festuccia, et al.
Bone Marrow Transplantation|February 10, 2015
Markers of coagulation activation and acute kidney injury in patients after hematopoietic cell transplantationS R Hingorani, K Seidel, E Pao, et al.
Bone Marrow Transplantation|February 10, 2015
Allo-SCT for myelofibrosis: reversing the chronic phase in the JAK inhibitor era?R Tamari, T I Mughal, D Rondelli, et al.
Bone Marrow Transplantation|July 25, 2012
Early-phase GVHD gene expression profile in target versus non-target tissues: kidney, a possible target?B Sadeghi, H Al-Chaqmaqchi, S Al-Hashmi, et al.
Bone Marrow Transplantation|July 25, 2012
PBSC mobilization in newly diagnosed patients with POEMS syndrome: outcomes and prognostic factorsJ Li, W Zhang, M H Duan, et al.
Bone Marrow Transplantation|July 30, 2022
Disease progression, treatments, hospitalization, and clinical outcomes in acute GVHD: a multicenter chart reviewShernan G Holtan, Jingbo Yu, Hannah K Choe, et al.
Bone Marrow Transplantation|May 17, 2023
Clinical relevance of MYC/BCL2 expression and cell of origin in patients with diffuse large b-cell lymphoma treated with autologous transplantTaha Al-Juhaishi, Yingjun Wang, Denái R Milton, et al.
Pageof 991